Table 3 Health-related quality of life (HRQL) outcomes at six months after NovaSure™ endometrial ablation: outpatient local anaesthetic treatment versus day-case general anaesthetic treatment
Outcome measure* | Inpatient (n=13) | Outpatient (n=17) |
|---|---|---|
Before your operation, how much trouble did your bleeding/pain symptoms cause? | ||
• A lot | 8/13 (62%) | 14/17 (82%) |
• Quite a bit | 4/13 (30%) | 3/17 (18%) |
• Some | 1/13 (8%) | |
Since your operation, how much trouble has your bleeding/pain caused? | ||
• None | 5/13 (38%) | 8/17 (46%) |
• A little | 3/13 (23%) | 3/17 (18%) |
• Some | 1/13 (8%) | 2/17 (12%) |
• Quite a bit | 4/13 (31%) | 3/17 (18%) |
• A lot | 0/13 (0%) | 1/17 (6%) |
General health in the past 4 weeks | ||
• Excellent | 3/13 (23%) | 2/17 (12%) |
• Very good | 3/13 (23%) | 3/17 (18%) |
• Good | 6/13 (46%) | 10/17 (58%) |
• Fair | 1/13 (8%) | 2/17 (12%) |
Sex life now | ||
• Not applicable | 1/13 (8%) | 1/17 (6%) |
• Worse | 0/13 (0%) | 1/17 (6%) |
• No difference | 11/13 (84%) | 10/17 (58%) |
• Improved | 1/13 (8%) | 5/17 (30%) |
Median disease-specific HRQL† | ||
• Before | 31 | 39.8 |
• After | 100 | 89.65 |